PT89573A - Metodo para a reducao de respostas mediadas por imunoglobulina e - Google Patents

Metodo para a reducao de respostas mediadas por imunoglobulina e

Info

Publication number
PT89573A
PT89573A PT89573A PT8957389A PT89573A PT 89573 A PT89573 A PT 89573A PT 89573 A PT89573 A PT 89573A PT 8957389 A PT8957389 A PT 8957389A PT 89573 A PT89573 A PT 89573A
Authority
PT
Portugal
Prior art keywords
immunoglobulin
reduction
mediated responses
antagonist
human interleukin
Prior art date
Application number
PT89573A
Other languages
English (en)
Other versions
PT89573B (pt
Inventor
Robert L Coffman
Jan Egbert De Vries
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT89573(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of PT89573A publication Critical patent/PT89573A/pt
Publication of PT89573B publication Critical patent/PT89573B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT89573A 1988-02-02 1989-01-31 Metodo para a reducao de respostas mediadas por imunoglobulina e PT89573B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02

Publications (2)

Publication Number Publication Date
PT89573A true PT89573A (pt) 1989-10-04
PT89573B PT89573B (pt) 1994-01-31

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89573A PT89573B (pt) 1988-02-02 1989-01-31 Metodo para a reducao de respostas mediadas por imunoglobulina e

Country Status (20)

Country Link
US (1) US5676940A (pt)
EP (2) EP0327283B1 (pt)
JP (1) JPH03500050A (pt)
KR (1) KR900700132A (pt)
AT (1) ATE93144T1 (pt)
AU (1) AU629536B2 (pt)
CA (1) CA1341477C (pt)
DE (1) DE68908431T2 (pt)
DK (1) DK183590A (pt)
ES (1) ES2058490T3 (pt)
FI (1) FI903827A0 (pt)
HK (1) HK35196A (pt)
HU (1) HU211059B (pt)
IE (1) IE63097B1 (pt)
IL (1) IL89124A (pt)
MY (1) MY107079A (pt)
NZ (1) NZ227812A (pt)
PT (1) PT89573B (pt)
WO (1) WO1989006975A1 (pt)
ZA (1) ZA89766B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991007986A1 (en) * 1989-12-04 1991-06-13 Schering Corporation Method of treating septic shock
CA2071908C (en) * 1989-12-20 2002-04-30 Lata Ramanathan Antibody antagonists of human interleukin-4
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
EP2990420B1 (en) 2000-05-26 2016-12-21 Immunex Corporation Use of interleukin-4 receptor antibodies and compositions thereof
RU2003127367A (ru) 2001-03-12 2005-03-20 Аванир Фармасьютиклз (Us) Бензимидазоловые соединения для модулирования ige и ингибирования клеточной пролиферации
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0255547A1 (en) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes

Also Published As

Publication number Publication date
ZA89766B (en) 1989-09-27
EP0397764A1 (en) 1990-11-22
DK183590D0 (da) 1990-08-01
IE63097B1 (en) 1995-03-22
EP0327283A1 (en) 1989-08-09
DE68908431D1 (de) 1993-09-23
NZ227812A (en) 1991-09-25
AU629536B2 (en) 1992-10-08
HUT54214A (en) 1991-01-28
ATE93144T1 (de) 1993-09-15
DK183590A (da) 1990-09-27
DE68908431T2 (de) 1993-12-23
US5676940A (en) 1997-10-14
MY107079A (en) 1995-09-30
AU3038389A (en) 1989-08-25
IL89124A (en) 1994-10-21
KR900700132A (ko) 1990-08-11
HU891044D0 (en) 1990-11-28
WO1989006975A1 (en) 1989-08-10
HK35196A (en) 1996-03-08
EP0327283B1 (en) 1993-08-18
PT89573B (pt) 1994-01-31
CA1341477C (en) 2005-03-29
IE890302L (en) 1989-08-02
IL89124A0 (en) 1989-08-15
FI903827A0 (fi) 1990-08-01
HU211059B (en) 1995-10-30
ES2058490T3 (es) 1994-11-01
JPH03500050A (ja) 1991-01-10

Similar Documents

Publication Publication Date Title
PT89573A (pt) Metodo para a reducao de respostas mediadas por imunoglobulina e
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
ES2062032T3 (es) Antagonista de interleuquina-5 para prevenir o reducir la eosinofilia.
ES2062762T3 (es) Metodo para tratar el choque septico.
FI924278A (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930707